Presentations and documents tagged “medelis”
-
Adaptive Trial Design in Phase I-II
from medelis, posted 1 month ago in Health & Medicine, Business & Mgmt. 198 views
Adaptive trial design is a hot issue in the drug development community. Adaptive conferences and web seminars abound, and suddenly, every consultant or vendor to the industry has become an adaptive expert. The FDA and EMEA are also much mo...
-
Context Of Vulnerability in Oncology Drug Dev...
from medelis, posted 2 years ago in Health & Medicine. 469 views
Renowned cancer researcher Dr. Daniel Von Hoff and his team at TGen are fervent believers in a new approach to developing novel therapies for patients with pancreatic cancer. Their rationale, dubbed “context of vulnerability,” is a powerful...
-
The Lost Art Of Phase I Oncology Trials
from medelis, posted 2 years ago in Health & Medicine, Business & Mgmt. 1216 views
Traditionally, oncology drug developers have regarded the phase I clinical trial as having a utility limited to the assessment of safety, tolerability, and pharmacokinetics and pharmacodynamics of a drug.
In this issue of Peer Perspecti...
-
Medelis: An Introduction to our Oncology CRO Se...
from medelis, posted 2 years ago in Health & Medicine, Business & Mgmt. 1373 views
A basic presentation we use to introduce biotech and pharmaceutical companies to the oncology contract research services Medelis provides to sponsors in the U.S., Europe and Asia.
-
Preclinical Trials: A Nuanced Study Process to...
from medelis, posted 2 years ago in Health & Medicine, Business & Mgmt. 1876 views
A Q&A with Dr. Mike McGarry, VP of Preclinical Study at Medelis. He describes a nuanced preclinical study process that can help a biotech Chief Medical Officer get into the clinic faster. This approach hinges on a strategic, well-defined r...
-
Dr. Dan Von Hoff discusses the complete phase I...
from medelis, posted 2 years ago in Health & Medicine, Business & Mgmt. 1208 views
A Q&A with renowned oncology investigator Dr. Daniel D. Von Hoff, M.D., who describes "the complete phase 1b," a clinical trial design that streamlines phase I by testing various drug combinations in one trial with multiple arms running in ...
